Hematophagic histiocytosis: A report of 23 new patients and a review of the literature

Medicine (United States)

Volumn 67, Issue 6, 1988, Pages 369-388

  Reiner, Alexander P ^a   Spivak, Jerry L ^a   Dietz, Nancy ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BLOOD CLOTTING DISORDER; FATALITY; FEMALE; HEMOPHAGOCYTOSIS; HISTIOCYTOSIS; HISTOLOGY; HUMAN; INFECTION; KIDNEY FAILURE; LIVER DYSFUNCTION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRIORITY JOURNAL; REVIEW;

ADULT; AGED; CASE REPORT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTES; HISTIOCYTOSIS, MALIGNANT; HUMAN; MALE; MIDDLE AGE; PANCYTOPENIA; PHAGOCYTOSIS; RETICULOENDOTHELIOSIS; SYNDROME;

EID: 0024235876     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/00005792-198811000-00002     Document Type: Article

References (107)

1. Abele DC, Griffin TB. Histiocytic medullary reticulosis: Report of two cases and review of the literature. Arch Dermatol 106: 319-329, 1972.
2. Abramson N, von Kapff C, Ginsburg AD. The phagocytic plasma cells. N Engl J Med 283: 248-250, 1970.
3. Auerbach M, Haubenstock A, Soloman G. Systemic babesiosis: Another cause of the hemophagocytic syndrome. Am J Med 80: 301-303, 1986.
4. Aviles A. Malignant histiocytosis and acute monocytic leukemia. Am J Med 83: 198-199, 1987.
5. Baer MR, Gleaton JH, Salhany KE, Glick AD. Malignant histiocytosis occurring with acute myelogenous leukemia in a patient with longstanding polycythemia vera. Cancer 59: 489-495, 1987.
6. Baer MR, Krantz SB, Cousar JB, Glick AD, Collins RD. Malignant histiocytoses developing in patients with B-cell lymphomas: Report of two cases. Cancer 57: 2175-2184, 1986.
7. Barnes N, Bellamy D, Ireland R, Parsons V, Costello J. Pulmonary tuberculosis complicated by haemophagocytic syndrome and rifampicin-induced tubulointerstitial nephritis. Br J Dis Chest 78: 395-403, 1984.
8. Brady RO. The lipid storage diseases: New concepts and control. Ann Intern Med 82: 257-261, 1975.
9. Broeckaert-von Orshoven A, Michielsen P, Vandepitte J. Fatal leishmaniasis in renal transplant patient. Lancet 2: 740-741, 1979.
10. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon* y. J Immunol 136: 4487-4495, 1986.
11. Butterworth CE Jr, Frommeyer WB, Riser WH. Erythrophago-cytosis in a case of plasma cell leukemia. Blood 8: 519-523, 1953.
12. Campo E, Condom E, Miro M-J, Cid M-C, Romagosa V. Tuberculosis-associated hemophagocytic syndrome. Cancer 58: 2640-2645, 1986.
13. Carney WP, Rubin RH, Hoffman RA, Hansen WP, Healey K, Hirsch MS. Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol 126: 2114-2116, 1981.
14. Ciistoldi G, Grusovin GD, Scapoli G, Gualandi M, Spanedda R, Anzanel D. Acute myelomonocytic leukemia terminating in histiocytic medullary reticulosis. Cancer 40: 1735-1747, 1977.
15. Chandra P, Chaudhery SA, Rosner F, Kagen M. Transient histiocytosis with striking phagocytosis of platelets, leukocytes, and erythrocytes. Arch Intern Med 135: 989-991, 1975.
16. Christensson B, Braconier JH, Winqvist I, Relander T, Dictor M. Fulminant course of infectious mononucleosis with virus-associated hemophagocytic syndrome. Scand J Infect Dis 19: 373-379, 1987.
17. Cline MJ. Defective mononuclear phagocyte function in patients with myelomonocytic leukemia and in some patients with lymphoma. J Clin Invest 52: 2185-2190, 1973.
18. Colon-Otero G, Li C-Y, Dewald GW, White WL. Erythrophagocytic acute lymphocytic leukemia with B-cell markers and with a 20q-chromosome abnormality. Mayo Clin Proc 59: 678-682, 1984.
19. Davis WC, Huber H, Douglas SD, Fudenberg HH. A defect in circulating mononuclear phagocytes in chronic granulomatous disease of childhood J Immunol 101: 1093-1095, 1968.
20. Degliantoni G, Murphy M, Kobayashi M, Francis MK, Perussia B, Trinchieri G. Natural Killer (NK) cell-derived hematopoietic colony inhibiting activity and NK cytotoxic factor. Relationship with tunmor necrosis factor and synergism with immune interferon. J Exp Med 162: 1512-1530, 1985.
21. Economopoulos TC, Stathakis N, Stathopoulos E, Alexopoulos C. 'Lennert's lymphoma' terminating as malignant histiocytosis. Scand J Haematol 23: 427-432, 1979.
22. Elsbach P. Lipid metabolism by phagocytes. Semin Hematol 9: 227-239, 1972.
23. Esseltine DW, DeLeeuw NKM, Berry GR. Malignant histiocytosis. Cancer 52: 1904-1910, 1983.
24. Estrov Z, Bruck R, Shtalrid M, Berrebi A, Resnitzky P. Histiocytic hemophagocytosis in Q fever. Arch Pathol Lan Med 108: 7, 1984.
25. Esumi N, Ikushima S, Todo S, Imashuku S. Hyperferritinemia in malignant histiocytosis and virus-associated hemophagocytic syndrome. N Engl J Med 316: 346-347, 1987.
26. Ezdinli EZ, Kucuk O, Chedid A, Sinclair TF, Thomas K, Singh S, Sarpel S, Jovanovic L. Hypogammaglobulinemia and hemophagocytic syndrome associated with lymphoproliferative disorders. Cancer 57: 1024-1037, 1986.
27. Falini B, Bucciarelli E, Grignani F, Martelli MF. Erythro-phagocytosì8 by undifferentiated lung carcinoma cells. Cancer 46: 1140-1145, 1980.
28. Femandes-Costa F, Eintracht I. Histiocytic medullary reticulosis. Lancet 2: 204-205, 1979.
29. Fitchen JH, Lee S. Phagocytic myeloma cells. Am J Clin Pathol 71: 722-723, 1979.
30. Foadi MD, Slater AM, Pegrum GD. Erythrophagocytosis by acute lymphoblastic leukaemic cells. Scand J Haematol 20: 85-88, 1978.
31. Gallin JI, Klimerman JA, Padgett GA, Wolif SM. Defective mononuclear leukocyte chemotaxis in the Chediak-Higashi syndrome of humans, mink, and cattle. Blood 45: 863-870, 1975.
32. Gill K, Marrie TJ. Hemophagocytosis secondary to mycoplasma pneumoniae infection. Am J Med 82: 668-670, 1987.
33. Golde DW, Finley TN, Cline MJ. Production of colony-stimulating factory by human macrophages. Lancet 2: 1397-1399, 1972.
34. Groopman JE, Golde DW. The histiocytic disorders: A pathophysiologic analysis. Ann Intern Med 94: 95-107, 1981.
35. Hanada T, Yamamura H, Isobe T, Nakazawa M, Abe T, Takita H. Pure red cell apasia in association with malignant histiocytosis. Cancer 57: 2325-2328, 1986.
36. Harada S, Sakamoto K, Seeley JK, Lindsten T, Bechtold T, Yetz J, Rogers G, Pearson G, Purtilo DT. Immune deficiency in the x-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects. J Immunol 129: 2532-2535, 1982.
37. Jaffee E, Costa J, Fauci AS, Cossman J, Tsokos M. Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med 75: 741-749, 1983.
38. James LP, Stass SA, Peterson V, Schumacher HR. Abnormalities of bone marrow simulating histiocytic medullary reticulosis in a patient with gastric carcinoma. Am J Clin Pathol 7: 600-602, 1979.
39. Johnston RB Jr. Monocytes and macrophages. N Engl J Med 318: 747-752, 1988.
40. Kadin ME, Kamoun M, Lamberg J. Erythrophagocytic T lymphoma. N Engl J Med 304: 648-653, 1981.
41. Kaneko YH, Kikuchi M, Ishihara A, Abe R, Takayama S Sakurai M. Chromosome abnormalities in malignant histiocytosis. Cancer 56: 144-151, 1985.
42. Keene WR, Jankl JH. Studies of the reticuloendothelial mass and sequestering function of rat bone marrow. Blood 26: 157-175, 1965.
43. Kim TH, Chan WC, Alvarado C, Zarrouk SO, Ragab AH. Malignant histiocytosis after lymphoblastic lymphoma. Am J Dis Child 137: 474-476, 1983.
44. Kitchens CS. Clinical observations of human bone marrow macrophages. Medicine 56: 503-513, 1977.
45. Kokkini G, Giotaki HG, Moutsopoulos HM. Transient hemo-phagocytosis in Brucella melitensis infection. Arch Pathol Lab Med 108: 213-216, 1984.
46. Korman LY, Smith JR, Landaw SA, Davey FR. Hodgkin's disease: Intramedullary phagocytosis with pancytopenia. Ann Intern Med 91: 60-61, 1979.
47. Ladisch S, Poplack DG, Holiman B, Blaese RM. Immunodeficiency in familial erythrophagocytic lymphohistiocytosis. Lancet I: 581-583, 1978.
48. Lynch ED, Alfrey CP Jr. Histiocytic medullary reticulosis: Hemolytic anemia due to erythrophagocytosis by histiocytes. Ann Intern Med 63: 666-671, 1965.
49. MacGregor RR. Alcohol and immune defense. JAMA 256: 1474-1479, 1986.
50. Mallick NP, Davson J. Is histiocytic medullary reticulosis a fatal form of infectious mononucleosis? Lancet 2: 43, 1981.
51. Mamus SW, Beck-Schroeder S, Zemjani ED. Suppression of normal human erythropoiesis by gamma interferon in vitro: Role of monocytes and T lymphocytes. J Clin Invest 75: 1496-1503, 1985.
52. Manoharan A, Catovsky D. Histiocytic medullary reticulosis revisited. In: Schmalzl F, Huhn D, Schaefer HE, eds. Disorders of the Monocyte Macrophage System. Berlin: Springer-Verlag, pp. 205-210, 1981.
53. Manoharan A, Catovsky D, Lampert LA, Mashadhani A, Gordon-Smith EC, Galton DAG. Histiocytic medullary reticulosis complicating chronic lymphocytic leukaemia: Malignant or reactive? Scand J Haematol 26: 5-13, 1981.
54. Manoharan A, Painter D. Histiocytic medullary reticulosis. Lancet 2: 881, 1982.
55. Marin-Padilla M. Erythrophagocytosis by epithelial cells of a breast carcinoma. Cancer 39: 1085-1089, 1977.
56. Martelli MF, Tabilio A, Aversa F, Falini B. Is histiocytic medullary reticulosis an infectious disease? Lancet 2: 446-447, 1982.
57. Martin-Moreno S, Soto-Guzman O, Beraaldo-De-Quiros J, Reverte-Cejudo D, Bascones-Casas C. Pancytopenia due to hemophagocytosis in patients with brucellosis: A report of four cases. J Infect Dis 147: 445-449, 1983.
58. Matzner Y, Behar A, Bern E, Gunder AE, Hershko C. Systemic leishmaniasis mimicking malignant histiocytosis. Cancer 43: 398-402, 1979.
59. McKenna RW, Risdall RJ, Brimning RD. Virus associated hemophagocytic syndrome. Human Pathol 12: 395-398, 1981.
60. Meagher RC, Sieber F, Spivak JL. Suppression of hematopoietic-progenitor-cell proliferation by ethanol and acetaldehyde. N Engl J Med 307: 845-849, 1982.
61. Mildvan D, Mathur U, Enlow RW, Romain PL, Winchester RJ, Colp C, Singman H, Adelsberg BR, Spigland I. Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med 96: 700-704, 1982.
62. Mills MJ. Post-viral haemophagocytic syndrome. J Roy Soc Med 75: 555-557, 1982.
63. Mroczek EC, Weisenburger DD, Grierson HL, Markin R, Purtilo DT. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 111: 530-535, 1987.
64. Murphy M, Loudon R, Kobayashi M, Trinchieri G. Y-interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation. J Exp Med 164: 263-279, 1986.
65. Murray HW. Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann Intern Med 108: 595-608, 1988.
66. Natelson EA, Lynch EC, Hettig RA, Alfrey CP. Histiocytic medullary reticuloeis. Arch Intern Med 122: 223-229, 1968.
67. Nathan CF, Murray HW, Cohn ZA. The macrophage as an effector cell. N Engl J Med 303: 622-626, 1980.
68. Ng C-S, Chan JKC, Cheng PNM, Szeto S-C. Nasal Tell lymphoma associated with hemophagocytic syndrome. Cancer 58: 67-71, 1986.
69. Pace JL, Russell SW, Schreiber RD, Altman A, Katz DH. Macrophage activation: Priming activity from a T-cell hybridoma is attributable to interferony. Proc Natl Acad Sci 80: 3782-86 1983.
70. Pileri S, Mazza P, Rivano MT, Martinelli G, Cavazzini G, Gobbi M, Taruscio D, Lauria F, Tura S. Malignant histiocytosis (true histiocytic lymphoma) clinicopathological study of 25 cases. Histiopathology 9: 905-920, 1985.
71. Prokocimer M, Inbal A, Gelber M, Shohat B, Basat MB, Shaklai M. Hemophagocytosis simulating malignant histiocytosis: A terminal event of the myelodysplastic syndrome. Acta Haematol 74: 164-167, 1985.
72. Rappaport H. Tumors of the hematopoietic system. In: Atlas of Tumor Pathology. Washington, D.C.: Armed Forces Institutes of Pathology, pp. 49-63, 1966.
73. Ree HJ, Kadin ME. Lectin distinction of benign from malignant histiocytes. Cancer 56: 2046-2050, 1985.
74. Reed SG, Nathan CF, Pihl DL, Rodricks P, Shanebeck K, Conlon PJ, Grabstein KH. Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide: Comparison with interferon-7. J Exp Med 166: 1734-1746, 1987.
75. Reinherz EL, O'Brien C, Rosenthal P, Schlossman SF. The cellular basis for viral-induced immunodeficiency: Analysis by monoclonal antibodies. J Immunol 125: 1269-1274, 1980.
76. Reisman RP, Greco MA. Virus-associated hemophagocytic syndrome due to Epstein-Barr virus. Hum Pathol 15: 290-293, 1984.
77. Risdall RJ, Brunning RD, Hernandez JI, Gordon DH. Bacteria-associated hemophagocytic syndrome. Cerncer 54: 2968-2972, 1984.
78. Risdall RJ, McKenna RW, Nesbit ME, Drivit W, Balfour HH Jr. Simmons RL, Brunning RD. Virus-associated hemophagocytic syndrome: A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44: 993-1002, 1979.
79. Root RK, Rosenthal AS, Balestra DJ. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi syndrome leukocytes. J Clin Invest 51: 649-665, 1972.
80. Rosenthal AS. Regulation of the immune response: Role of the macrophage. N Engl J Med 303: 1153-1156, 1980.
81. Rosner F, Grunwald HW. Association of T cell acute lymphoblastic leukemia and histiocytic medullary reticulosis. Am J Med 77: 910-914, 1984.
82. Rubin M, Rothenberg SP, Panchacharam P. A histiocytic medullary reticulosis-like syndrome as the terminal event in lymphocytic lymphoma. Am J Med Sci 287: 62-63, 1984.
83. Schechter GP, Guecion J, Matthews M, Fischmann AB, Bunn PA. Erythrophagocytic T lymphoma. N Engl J Med 305: 103-104, 1981.
84. Schooley JC, Kullgren B, Allison AC. Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anemias. Br J Haematol 67: 11-17, 1987.
85. Schooley RT, Hiraeh MS, Colvin RB, Cosimi AB, Tolkoff-Rubin NE, McCluskey RT, Burton RC, Russell PS, Herrin JT, Delmonieo FL, Giorgi JV, Henle W, Rubin RH. Association of herpesvirus infections with T-Iymphocyte subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med 308: 307-313, 1983.
86. Schultz RM, Kleinschmidt WJ. Functional identity between murine interferon and macrophage activating factor. Nature 305: 239-240, 1983.
87. Scott RB, Robb-Smith AHT. Histiocytic medullary reticulosis. Lancet 2: 194-198, 1939.
88. Seligman BR, Rosner F, Lee SL, Kagan MD. Histiocytic medullary reticulosis: Fatal hemorrhage due to massive platelet phagocytosis. Arch Intern Med 129: 109-113, 1972.
89. Shanley JD, Cline MJ. Phagocytosis of hematopoietic cells by blast cells in blast crisis of chronic myelocytic leukemia. Western J Med 126: 139-141, 1977.
90. Snyderman R, Altman LC, Frankel A, Blaese RM. Defective mononuclear leukocyte chemotaxis: A previously unrecognized immune dysfunction. Studies in a patient with chronic mucocutaneous candidiasis. Ann Intern Med 78: 509-513, 1973.
91. Spivak JL. Phagocytic tumor cells. Scand J Haemat 11: 253-256, 1973.
92. Spivak JL, Bender BS, Quinn TC. Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med 77: 224-228, 1984.
93. Theodorakis ME, Zamkoff KW, Davey FR, Ginsberg SJ, Cass DL, Gottlieb AJ. Acute nonlymphocytic leukemia complicated by severe cytophagocytosis of formed blood elements by nonmalignant histiocytes: Cause of significant clinical morbidity. Med Pediat Oncol 11: 20-26, 1983.
94. Tseng A Jr, Coleman CN, Cox RS, Colby TV, Turner RR, Horning SJ, Rosenberg SA. The treatment of malignant histiocytosis. Blood 64: 48-53, 1984.
95. Turner RR, Wood GS, Beckstead JH, Colby TV, Horning SJ, Wamke RA. Histiocytic malignancies: Morphologic, immunologic, and enzymatic heterogeneity. Am J Surg Pathol 8: 485-500, 1984.
96. Udden MM, Banez E, Sears DA. Bone marrow histiocytic hyperplasia and hemophagocytosis with pancytopenia in typhoid fever. Am J Med Sci 291: 396-400, 1986.
97. Unanue ER, Allen PM. The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236: 551-557, 1987.
98. Warake RA, Kim H, Dorfman RF. Malignant histiocytosis (histiocytic medullary reticulosis). I. Clinicopathologic study of 29 cases. Cancer 35: 215-230, 1975.
99. Weintraub M, Siegman-Igra Y, Josiphov J, Rahmani R, Liron M. Histiocytic hemophagocytosis in miliary tuberculosis. Arch Intern Med 114: 2055-2057, 1984.
100. Weiser WY, Van Niel A, Clark SC, David JR, Remold HG. Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages. J Exp Med 166: 1436-1446, 1987.
101. Wheeler MS, Wilson EC, Stass SA. Erythroleukophagocytosis by leukemic cells: A nonspecific finding. Am J Clin Pathol 75: 266-267, 1981.
102. Wick MR, Ducatman BS, Pierre RV. Histiocytic hemophagocytosis. Arch Pathol Lab Med 105: 115, 1981.
103. Wick MR, Li C-Y, Ludwig J, Levitt R, Pierre RV. Malignant histiocytosis as a termina] condition in chronic lymphocytic leukemia. Mayo Clin Proc 55: 108-112, 1980.
104. Wilson ER, Malluh A, Stagno S, Crist WM. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. J Pediatr 98: 260-262, 1981.
105. Woodruff RD, Nolting SF. Malignant histiocytosis as a sequal to lymphoblastic lymphoma. Arch Pathol Lab Med 105: 336-37, 1981.
106. Zuazu JP, Duran JW, Julia AF. Hemophagocytosis in acute brucellosis. N Engl J Med 301: 1185-1186, 1979.
107. Zuckerman KS. Human erythroid burst-forming units. Growth in vitro is dependent on monocytes, but not T lymphocytes. J Clin Invest 67: 702-709, 1981.